Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Surgery
|
May 4, 2025
Outcomes of neoadjuvant immunochemotherapy and neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
Kelong Shao, Yening Du, Liwei Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 25, 2025
Evolution of Multivalent Aptamer Corona for High-Throughput Multiplexed Detection of Multiple Cancers
Mengjie Wang, Baichuan Jin, Xin Dai, et al.
Journal of the American Chemical Society
|
October 23, 2025
Personalized Cancer-Specific Protein-Aptamer Corona for Orthogonal Multiplex Cancer Diagnosis
Jinlong Fan, Baichuan Jin, Xin Dai, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
October 18, 2020
[Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment]
Qingqing Hang, Hangjie Ying, Guoping Cheng, et al.
Journal of Cardiothoracic Surgery
|
December 28, 2024
Delineation of intersegmental plane: application of blood flow blocking method in pulmonary segmentectomy
Lei Cai, Changchun Wang, Taobo Luo, et al.
Plos One
|
April 21, 2015
Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy
Dan Su, Xinming Zhou, Qixun Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 1, 2024
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials
Yang Yang, Rongjun Shao, Xiufeng Cao, et al.
Oncotarget
|
June 1, 2016
Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma
Yun Fan, Youhua Jiang, Xinming Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma
Dijian Shen, Rui Li, Yong She, et al.
Journal of Thoracic Disease
|
March 13, 2023
Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)
Jun Yin, Siyun Lin, Yong Fang, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Surgery
|
May 4, 2025
Outcomes of neoadjuvant immunochemotherapy and neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
Kelong Shao, Yening Du, Liwei Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 25, 2025
Evolution of Multivalent Aptamer Corona for High-Throughput Multiplexed Detection of Multiple Cancers
Mengjie Wang, Baichuan Jin, Xin Dai, et al.
Journal of the American Chemical Society
|
October 23, 2025
Personalized Cancer-Specific Protein-Aptamer Corona for Orthogonal Multiplex Cancer Diagnosis
Jinlong Fan, Baichuan Jin, Xin Dai, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
October 18, 2020
[Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment]
Qingqing Hang, Hangjie Ying, Guoping Cheng, et al.
Journal of Cardiothoracic Surgery
|
December 28, 2024
Delineation of intersegmental plane: application of blood flow blocking method in pulmonary segmentectomy
Lei Cai, Changchun Wang, Taobo Luo, et al.
Plos One
|
April 21, 2015
Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy
Dan Su, Xinming Zhou, Qixun Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 1, 2024
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials
Yang Yang, Rongjun Shao, Xiufeng Cao, et al.
Oncotarget
|
June 1, 2016
Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma
Yun Fan, Youhua Jiang, Xinming Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 20, 2026
PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma
Dijian Shen, Rui Li, Yong She, et al.
Journal of Thoracic Disease
|
March 13, 2023
Neoadjuvant therapy with immunoagent (nivolumab) or placebo plus chemotherapy followed by surgery and adjuvant treatment in subjects with resectable esophageal squamous cell carcinoma: study protocol of a randomized, multicenter, double blind, phase II trial (NATION-2203 trial)
Jun Yin, Siyun Lin, Yong Fang, et al.
Page
of 9